Introduced Today in the Ohio House
FOR IMMEDIATE RELEASE, June 10, 2015 (Cincinnati, OH): Today, Representatives Tom Brinkman (R-Cincinnati) and Christina Hagan (R-Alliance) introduced the Abortion-Inducing Drug Safety Act (H.B. 255) in the Ohio House of Representatives.
This bill limits the use of abortion-inducing drugs to those labeled expressly for such purpose by the FDA. Currently, Mifeprex (mifepristone) is the only chemical labeled specifically for inducing abortion in the United States. While the combination of mifepristone and misoprostol is still the most common regimen used for chemical abortions, Ohio abortionists are also using other drugs such as methotrexate, labeled for use as a chemotherapy agent.
The Abortion-Inducing Drug Safety Act expands to other drugs the protections already granted to women who seek RU-486 chemical abortions in the state, under a law also sponsored by Rep. Brinkman. This original law mandates that physicians comply with FDA-approved protocol concerning when and how RU-486 can be used to cause an abortion, but does not address other abortion-inducing chemicals.
“To stop the natural process of pregnancy, these toxic chemicals are dangerous for women and lethal for their unborn children,” said Paula Westwood, Executive Director, Right to Life of Greater Cincinnati. “At the very least women deserve treatment, information, and followup care according to standard medical practice.”
Off label use of chemicals to cause abortions is on the rise nationwide. For more information see American’s United for Life’s analysis, Chemical Abortion: What We Don’t Know is as Scary as What We Do